Peter Yehl | LCGC

Peter Yehl

Separation Science in Drug Development, Part 4: Quality Control

LCGC Europe - Aug 01, 2016

This fourth and last instalment in the “Separation Science in Drug Development” series provides an overview of modern practices of quality control in small-molecule drug development, including activities such as setting specifications, method validation and transfer, release and stability testing, and authoring chemistry, manufacturing, and controls (CMC) sections of regulatory filings.

Separation Science in Drug Development, Part IV: Quality Control

LCGC North America - Dec 01, 2015

An overview of modern practices of quality control in small-molecule drug development

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

Pharmaceutical Technology - Oct 02, 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

Subscribe to LCGC magazine, e-newsletters, and LCGC's The Column here>>

PARTNER RESOURCES

	New GC Designed with the Analyst in Mind

	Multi-Residue Analysis of 18 Regulated Mycotoxins by LC-MS/MS

	Get a 76% Increase in Throughput for EPA Methods 625 and 8270

	Goal-Oriented Approach to the Quantitative Determination of Cannabinoids by HPLC

Sponsored By:

Jobs in Analytical Chemistry

You may have an excellent educational background, and perhaps some very good experience, too. But are you prepared to get—and keep—your next job in analytical chemistry? This collection of short articles from LCGC’s digital magazine, The Column, offers essential advice for separation scientists who aspire to get a new job and succeed once there.

Read more.